Triglyceride-Glucose Index Is a Useful Marker for Predicting Future Cardiovascular Disease and Mortality in Young Korean Adults: A Nationwide Population-Based Cohort Study
Journal of Lipid and Atherosclerosis · 2022 · 11 (2) · 178
DOI: 10.12997/jla.2022.11.2.178 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Lipid and Atherosclerosis, 2022. Verfasst von Yun Kyung Cho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Society of Lipid and Atherosclerosis, NHIS.
Abstract (Originalsprache)
Objective
The triglyceride-glucose (TyG) index, the product of fasting triglycerides and glucose, is a useful and cost-effective marker of insulin resistance (IR). Furthermore, the TyG index is a known IR screening tool in healthy young adults but not in those with atherosclerotic cardiovascular disease (CVD). Thus, this study aimed to evaluate the TyG index as a predictor of CVD in healthy young adults.
Methods
This study enrolled 6,675,424 adults aged 20-39 years without CVD from the National Health Information Database. We categorized them by TyG index quartile from 2009-2017. The study outcomes were stroke, myocardial infarction (MI), and mortality. All outcomes were analyzed by Cox proportional hazards regression analysis while controlling for baseline covariates.
Results
During a mean 7.4 years of follow-up, 8,506 cases of stroke, 12,312 cases of MI, and 22,667 deaths were recorded. Multivariable-adjusted hazard ratios (HRs) for participants in the highest TyG index quartile demonstrated that they were at higher risk for stroke (HR, 1.253; 95% confidence interval [CI], 1.167-1.346), MI (HR, 1.258; 95% CI, 1.187-1.334), and mortality (HR, 1.151; 95% CI, 1.104-1.200) than those in the lowest TyG index quartile independent of age, sex, smoking, alcohol consumption, physical activity, income, body mass index, blood pressure, and total cholesterol. The HRs for outcomes in the highest quartiles were higher when the TyG index was applied than when triglyceride or fasting glucose alone was applied.
Conclusion
TyG index, a simple measure reflecting IR, can predict CVD and mortality in young and healthy populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Asan Diabetes Center, Asan Medical Center, Seoul, Korea.
ORCID-Profile: Yun Kyung Cho, Kyung-do Han, Hwi Seung Kim, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee
Förderung
- Korean Society of Lipid and Atherosclerosis
- NHIS
Zitieren
APA
Cho, Y. K., Han, K. D., Kim, H. S., Jung, C. H., Park, J. Y., & Lee, W. J. (2022). Triglyceride-Glucose Index Is a Useful Marker for Predicting Future Cardiovascular Disease and Mortality in Young Korean Adults: A Nationwide Population-Based Cohort Study. Journal of Lipid and Atherosclerosis, 11(2), 178. https://doi.org/10.12997/jla.2022.11.2.178
Vancouver
Cho YK, Han KD, Kim HS, Jung CH, Park JY, Lee WJ. Triglyceride-Glucose Index Is a Useful Marker for Predicting Future Cardiovascular Disease and Mortality in Young Korean Adults: A Nationwide Population-Based Cohort Study. Journal of Lipid and Atherosclerosis. 2022;11(2):178. doi:10.12997/jla.2022.11.2.178
BibTeX
@article{Cho2022,
author = {Cho, Yun Kyung and Han, Kyung-do and Kim, Hwi Seung and Jung, Chang Hee and Park, Joong-Yeol and Lee, Woo Je},
title = {Triglyceride-Glucose Index Is a Useful Marker for Predicting Future Cardiovascular Disease and Mortality in Young Korean Adults: A Nationwide Population-Based Cohort Study},
journal = {Journal of Lipid and Atherosclerosis},
year = {2022},
volume = {11},
number = {2},
pages = {178},
doi = {10.12997/jla.2022.11.2.178}
}
EUVIMED